Phenobarbital IV (neonatal seizures)

فنوباربیتال وریدی (نوزاد)

⚠ Unverified

🧠 Nervous SystemBarbiturate anticonvulsant

Market / country: 🇺🇸 USA

Sezaby (US)

🧮 Dose calculator

Neonatal seizures · Regimen source: FDA Sezaby · 2.1, Table 1

  • • If seizures persist 15 min after the loading dose: a second dose (preterm 10 or 20 mg/kg; term 20 mg/kg). Total loading max 40 mg/kg. Into a large peripheral vein. FDA Sezaby · 2.1, Table 1
  • • Iran also has 100 and 200 mg/mL ampoules (Darooyab); the volume shown is for the 10 mg/mL reconstituted powder — with an Iranian ampoule compute the volume from the mg dose and that ampoule’s strength. Darooyab · G-677/Phenobarbital

Enter age and weight.

🛡️ Safety & information

Contraindications

  • ⛔ Acute porphyria; hypersensitivity to phenobarbital or barbiturates. FDA Sezaby · 4

Formulations

👥 Special populations

  • 🤰 PregnancyDangerous / avoid

    Darooyab: category D — evidence of fetal risk; only when essential. Darooyab · G-677/Phenobarbital — مصرف در بارداری

    “مصرف در بارداری فنوباربیتال گروه D استفاده نشود:”
  • 🤱 BreastfeedingNo data

    The source for this drug has no section for this group.

  • 👶 ChildrenUse with caution

    The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Sezaby · 8.4

    “The safety and effectiveness of SEZABY have been established for the treatment of neonatal seizures in term and preterm infants, and the information on this use is discussed throughout the labeling.”
  • 👴 Older adultsNo data

    The source for this drug has no section for this group.

  • ⚥ Females & males of reproductive potentialNo data

    The source for this drug has no section for this group.

📚 Reference status for this drug

Shows which sources have references recorded for this drug and which do not.

🔗 Similar drugs

Same class

Doz is only a support tool and does not replace clinical judgment or official sources. Check every dose against the original source before prescribing. About & disclaimer · Sources

Inspired by the Saphira project; part of the content is taken from it.

Contact and correction requests — Telegram: @cenaav